Company
QUEoncology
Developing novel non-hormonal therapies to address moderate to severe vasomotor symptoms in postmenopausal women, and in cancer patients receiving hormone therapy.
Also known as QUE Oncology
- Status
- Operatingas of 2026-09-19
- Founded
- 2013
Claim, correct or request removal
Record updated 19 September 2026
About
QUE Oncology is focused on unlocking the significant potential of its lead product Q-122 in development as a non-hormonal treatment for moderate to severe vasomotor symptoms (hot flashes and night sweats) in postmenopausal women, and in cancer patients receiving hormone therapy.
Products
- Other
- Q-122
Loading relationship preview